Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/07/2024 BST 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CONTEXT THERAPEUTICS INC.
Other Biotechnology & Medical Research
-0.45%+12.89% - - - 164M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Charts Context Therapeutics Inc.
  6. Comparison Chart